Evaluating the HLA-G (rs1063320) genetic variant and risk of human papillomavirus infection: a meta-analysis of 953 cases and 877 controls

References

• Adebamowo SN, Olawande O, Famooto A, Dareng EO, Offiong R, Adebamowo CA, H3Africa ACCME Research Group. 2017. Persistent low-risk and high-risk human papillomavirus infections of the uterine cervix in HIV-negative and HIV-positive women. Frontiers in Public Health 5:178.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Sharma M, Mangat N, Suri V, Bhatia T, Kumar P, Minz R. 2020. Understanding HLA-G driven journey from HPV infection to cancer cervix: adding missing pieces to the jigsaw puzzle. Journal of Reproductive Immunology 142:103205.
   PubMed Web of Science ®Google Scholar
• Bortolotti D, Gentili V, Rotola A, Di Luca D, Rizzo R. 2014. Implication of HLA-G 3′ untranslated region polymorphisms in human papillomavirus infection. Tissue Antigens 83:113–118.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre L, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Howangyin K-Y, Favier B, Lemaoult J. 2008. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Human Immunology 69:700–707.
   PubMed Web of Science ®Google Scholar
• Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. 2008. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72:335–341.
   PubMed Web of Science ®Google Scholar
• Cheng L, Guo Y, Zhan S, Xia P. 2018. Association between HLA-DP gene polymorphisms and cervical cancer risk: a meta-analysis. BioMed Research International 2018:1–13.
   Web of Science ®Google Scholar
• Clifford G, Smith J, Aguado T, Franceschi S. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. British Journal of Cancer 89:101–105.
   PubMed Web of Science ®Google Scholar
• Dong D-D, Yang H, Li K, Xu G, Song L-H, Fan X-L, et al. 2010. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response. Reproductive Sciences 17:718–723.
   PubMed Web of Science ®Google Scholar
• Ferguson R, Ramanakumar AV, Koushik A, Coutlee F, Franco E, Roger M, the Biomarkers of Cervical Cancer Risk Study Team. 2012. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. International Journal of Cancer 131:E312–E319.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, et al. 2002. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes & Control 13:839–846.
   PubMed Web of Science ®Google Scholar
• Gravitt PE. 2011. The known unknowns of HPV natural history. The Journal of Clinical Investigation 121:4593–4599.
   PubMed Web of Science ®Google Scholar
• Hicklin DJ, Marincola FM, Ferrone S. 1999. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Molecular Medicine Today 5:178–186.
   PubMedGoogle Scholar
• Isakova J, Vinnikov D, Bukuev N, Talaibekova E, Aldasheva N. 2019. ТР53 codon 72 polymorphism and human papilloma virus-associated cervical cancer in Kyrgyz women. Asian Pacific Journal of Cancer Prevention 20:1057–1062.
   PubMedGoogle Scholar
• Li X-J, Zhang X, Lin A, Ruan Y-Y, Yan W-H. 2012. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. Human Immunology 73:946–949.
   PubMed Web of Science ®Google Scholar
• Pelullo CP, Esposito MR, Di Giuseppe G. 2019. Human papillomavirus infection and vaccination: knowledge and attitudes among nursing students in Italy. International Journal of Environmental Research and Public Health 16:1770.
   Web of Science ®Google Scholar
• Silva ID, Muniz YC, Sousa MC, Silva KR, Castelli EC, Jose Filho C, et al. 2013. HLA-G 3′ UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Human Immunology 74:452–458.
   PubMed Web of Science ®Google Scholar
• Strong C, Yu Y-F, Zou H, Ku W-W, Lee C-W, Ko N-Y. 2019. Sexual network and detection of anogenital human papillomavirus in a community cohort of men who have sex with men in Taiwan. PLOS One 14:e0216784.
   PubMed Web of Science ®Google Scholar
• Vermeulen CF, Jordanova ES, Zomerdijk-Nooijen YA, Ter Haar NT, Peters AA, Fleuren GJ. 2005. Frequent HLA class I loss is an early event in cervical carcinogenesis. Human Immunology 66:1167–1173.
   PubMed Web of Science ®Google Scholar
• Xu HH, Shi WW, Lin A, Yan WH. 2014. HLA‐G 3′ untranslated region polymorphisms influence the susceptibility for human papillomavirus infection. Tissue Antigens 84:216–222.
   PubMedGoogle Scholar
• Xu H-H, Zhang X, Zheng H-H, Han Q-Y, Lin A-F, Yan W-H. 2018. Association of HLA-G 3′ UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections. Infectious Agents and Cancer 13:42.
   PubMed Web of Science ®Google Scholar
• Yang Y-C, Chang T-Y, Chen T-C, Lin W-S, Chang S-C, Lee Y-J. 2014. Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women. European Journal of Cancer 50:469–474.
   PubMed Web of Science ®Google Scholar
• Yoon B, Kim Y, Kim J, Kim S, Kim J, Kim SW. 2007. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. International Journal of Gynecology & Obstetrics 98:48–53.
   PubMed Web of Science ®Google Scholar
• Zheng N, Wang CX, Zhang X, Du LT, Zhang J, Kan SF, et al. 2011. Up‐regulation of HLA‐G expression in cervical premalignant and malignant lesions. Tissue Antigens 77:218–224.
   PubMedGoogle Scholar